Tumor Mutation Burden (Tmb) Is Associated With Improved Efficacy Of Atezolizumab In 1l And 2l+Nsclc Patients F. Griesinger,M. Kowanetz,W. Zou,D. S. Shames,C. A. Cummings,N. A. Rizvi,A. Spira,G. Frampton, V. Leveque,S. Flynn,S. Mocci,G. Shankar,R. Funke,M. Ballinger,D. Waterkamp, D. S. Chen,A. Sandler,G. Hampton,L. C. Amler, P. Hedge,M. D. HellmannJOURNAL OF THORACIC ONCOLOGY（2017）引用 1|浏览24暂无评分关键词Immunotherapy,mutational load,NSCLC,BiomarkersAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
